FDA Inspection 1036703 — Pfizer Manufacturing Belgium NV

Pfizer Manufacturing Belgium NV — FEI 1000654629

The FDA completed an inspection of Pfizer Manufacturing Belgium NV on November 16, 2017 in Puurs-Sint-Amands. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 16, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Puurs-Sint-Amands (Belgium)